NASDAQ:ADMA
ADMA Biologics Inc Stock News
$6.55
+0.110 (+1.71%)
At Close: Apr 26, 2024
ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments
07:35am, Thursday, 07'th May 2020
RAMSEY, N.J. and BOCA RATON, Fla., May 07, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, m
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q1 2020 Results - Earnings Call Transcript
02:32am, Thursday, 07'th May 2020
Start Time: 16:30 End Time: 17:13 ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2020 Earnings Conference Call May 06, 2020, 16:30 PM ET Company Participants Adam Grossm
Adma Biologics (ADMA) Reports Q1 Loss, Misses Revenue Estimates
12:15am, Thursday, 07'th May 2020
Adma Biologics (ADMA) delivered earnings and revenue surprises of -100.00% and -4.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q1 2020 Results - Earnings Call Transcript
10:32pm, Wednesday, 06'th May 2020
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q1 2020 Results - Earnings Call Transcript
Adma Biologics (ADMA) Reports Q1 Loss, Misses Revenue Estimates
08:15pm, Wednesday, 06'th May 2020
Adma Biologics (ADMA) delivered earnings and revenue surprises of -100.00% and -4.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
ADMA Biologics Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
08:05pm, Wednesday, 06'th May 2020
Achieved First Quarter 2020 Total Revenues of $10.2 Million, a 189% Increase Over First Quarter 2019 Strengthened Balance Sheet Through Successful Completion of Underwritten.
These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand
06:50pm, Wednesday, 06'th May 2020
A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel...
When will we be going to concerts and sporting events again? Here's what experts are saying
01:02pm, Wednesday, 06'th May 2020
Getting back to normal societal rhythms will be a gradual process, and large gatherings may be one of the last things to return, say health experts and government officials.
Coronavirus Symptoms and How to Protect Yourself: What We Know
11:24am, Wednesday, 06'th May 2020
Concern is high about the deadly virus behind a fast-growing global outbreak. Here is what health officials know so far.
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
5 a.m. wake ups and 1,000 emails: Inside a typical day for White House Advisor Dr. Anthony Fauci
06:51pm, Tuesday, 05'th May 2020
As the coronavirus pandemic enters its third month, White House Advisor Anthony Fauci says his schedule is still nearly impossible. The infectious disease doctor gives National Geograhpic a detailed a
U.S. lawmakers question Jaguar Health on price hike of drug that may help treat COVID-19 patients
06:59pm, Monday, 04'th May 2020
The chair of a House of Representatives committee and a fellow Democratic committee member on Monday urged Jaguar Health Inc to reverse recent price hikes of a drug that could be used to treat side ef
Congresswomen urge Jaguar Health to reverse price hike on drug that may be used in COVID-19 patients
04:26pm, Monday, 04'th May 2020
Two congresswomen wrote a letter Monday urging drugmaker Jaguar Health Inc to reverse recent price hikes on its drug Mytesi, which could be used to alleviate side effects in patients being treated for
Congresswomen urge Jaguar Health to reverse price hike on drug that may be used in COVID-19 patients
12:00am, Monday, 04'th May 2020
Congresswomen urge Jaguar Health to reverse price hike on drug that may be used in COVID-19 patients